Publications by authors named "Daniela Castro"

This paper describes the results of the study I Want More! The Lives of Sex Workers During the COVID-19 Pandemic, which is part of the EPIC community research program. The study analyzed the effects of the pandemic on the lives of cis, trans and travesti sex workers in nine Brazilian states and 11 cities throughout 2020 and 2021. This article focuses on the qualitative component of the study, which was based on semi-structured, remote and face-to-face interviews carried out with 43 sex workers, and its comparison with the quantitative component.

View Article and Find Full Text PDF

Yeast and fibrolytic enzymes serve as additives incorporated into the nutrition of ruminants to regulate rumen fermentation and increase the digestibility of fiber, thereby enhancing the efficiency of rumen fermentation. Two experiments were conducted to assess the impact of five diets: a control diet without additives, diets with yeast (Saccharomyces cerevisiae) or exogenous fibrolytic enzymes (EFE), and diets with a blend of 0.7yeast + 0.

View Article and Find Full Text PDF

Supplementation with CBM588, a bifidogenic live bacterial product, has been associated with improved clinical outcomes in persons with metastatic renal cell carcinoma (mRCC) receiving nivolumab and ipilimumab. However, its effect on those receiving tyrosine kinase inhibitor-based combinations is unknown. In this open-label, randomized, investigator-initiated, phase 1 study, 30 participants with locally advanced or mRCC with histological confirmation of clear cell, papillary or sarcomatoid component were randomized in a 2:1 fashion to receive cabozantinib (an inhibitor of vascular endothelial growth factor receptor, MET and AXL) and nivolumab (anti-programmed cell death protein 1) with or without CBM588 as first-line treatment.

View Article and Find Full Text PDF
Article Synopsis
  • - A study assessed dietary changes and supplement use among patients with metastatic renal cell carcinoma, finding that 50.9% of respondents began using supplements post-diagnosis, with probiotics and CBD being the most popular.
  • - The survey, conducted by KCCure, gathered data from 289 patients on their dietary patterns, supplement expenses, and perceptions of alternative medicine.
  • - Results indicated that 34.9% of patients made dietary modifications, predominantly adopting the Mediterranean and ketogenic diets, highlighting the need for doctors to discuss supplement use with their patients as these practices may influence cancer treatment outcomes.
View Article and Find Full Text PDF

Background And Objective: The impact of time of metastasis onset with respect toprimary renal cell carcinoma (RCC) diagnosis on survival outcomes is not well characterized in the era of immune checkpoint inhibitor (ICI)-based combinations. Herein, we assessed differences in clinical outcomes between synchronous and metachronous metastatic RCC (mRCC).

Methods: Data for patients with mRCC treated with first-line ICI-based combination therapies between 2014 and 2023 were retrospectively collected.

View Article and Find Full Text PDF

Urbanization in watersheds leads to the introduction of sources of microplastics and other pollutants in water bodies. However, the effect of urbanization on microplastic pollution and the relationship between microplastics and water quality are not well understood. We assessed the distribution of microplastics in tributaries urbanized, non-urbanized and in the receiving lagoon body of Conceição Lagoon watershed.

View Article and Find Full Text PDF

We sought to determine racial and ethnic differences in perceptions (quality of communication, expectations, and concerns) of germline or somatic DNA sequencing (genomic profiling). Patients with prostate, urothelial, or kidney cancer were surveyed using a questionnaire that assessed previous experience, beliefs, expectations, and concerns regarding genomic profiling. Descriptive statistics and chi-square tests were used to identify factors associated with patients' perceptions of genomic profiling.

View Article and Find Full Text PDF
Article Synopsis
  • * FFPE samples from 33 RCC patients were examined, revealing significant differences in immune cell proportions, particularly with higher CD4 and CD8 T cell levels in clear cell RCC compared to papillary RCC.
  • * Patients with clear cell RCC showed better median overall survival rates than those with papillary RCC, highlighting important variations in tumor characteristics and immune profiles between the two subtypes.
View Article and Find Full Text PDF

Objectives: To characterise the restrictiveness of eligibility criteria in contemporary renal cell carcinoma (RCC) trials, using recommendations from the American Society of Clinical Oncology (ASCO)-Friends of Cancer Research (FCR) initiative.

Methods: vPhase I-III trials assessing systemic therapies in patients with RCC starting between 30 June 2012 and 30 June 2022 were identified. Eligibility criteria regarding brain metastases, prior or concurrent malignancies, hepatitis B virus (HBV) or hepatitis C virus (HCV) infection, and human immunodeficiency virus (HIV) infection were identified and stratified into three groups: exclusion, conditional inclusion, and not reported.

View Article and Find Full Text PDF

Background: Preclinical evidence demonstrating circadian rhythmicity within the immune system provides a rationale for hypothesis that immune checkpoint inhibitor (ICI) infusion time-of-day may serve as an actionable mechanism to improve outcomes. Herein, we explore the association between ICI time of infusion (TOI) and outcomes in metastatic renal cell carcinoma (mRCC).

Methods: Data from patients with mRCC who received nivolumab or nivolumab/ipilimumab, in first- or second-line were retrospectively collected.

View Article and Find Full Text PDF

Background: There are limited data regarding the impact of ethnicity among patients receiving immune checkpoint inhibitors. We evaluated real-world outcomes between Latinx and non-Latinx patients with metastatic renal-cell carcinoma (mRCC) treated with first-line nivolumab/ipilimumab within 2 different healthcare settings.

Methods: We performed a retrospective analysis of patients with mRCC who received nivolumab/ipilimumab within the Los Angeles County Department of Health Services (LAC-DHS), a safety-net healthcare system, and the City of Hope Comprehensive Cancer Center (COH), a tertiary oncology center, between January 1, 2015 and December 31, 2021.

View Article and Find Full Text PDF

Background: We explored changes in perceptions of cure among patients with genitourinary (GU) cancers starting Immune checkpoint inhibitors (ICIs) therapy.

Materials And Methods: This longitudinal study assessed patients before starting therapy and 3-months later with a questionnaire that included patient perceptions of ICIs and the Patient-Reported Outcomes Measurement Information System (PROMIS) Anxiety scale. General linear modeling was used to investigate changes in expectation of cure over time, and chi-square tests were used to determine the association between expectation of cure and perceptions of ICIs and anxiety.

View Article and Find Full Text PDF

Purpose: Eligibility criteria illustrate the characteristics of the study population and promote the safety of participants. However, overreliance on restrictive eligibility criteria may limit the generalizability of outcomes. As a result, the American Society of Clinical Oncology (ASCO) and Friends of Cancer Research (Friends) issued statements to curtail these challenges.

View Article and Find Full Text PDF

Purpose: We report two successful cases of treatment by steroids after severe inflammation due to an intravitreal injection (IVI) of brolucizumab and their retreatment with another type of anti-vascular endothelial growth factor (VEGF), with steroid treatments to prevent severe inflammatory recurrence in patients with exudative age-related macular degeneration (AMD). CLINICAL CASES, CASE 1: An 88-year-old woman with exudative AMD in her left eye who had persistent subretinal fluid despite receiving an IVI, including ranibizumab and, subsequently, aflibercept. A switch to brolucizumab was decided.

View Article and Find Full Text PDF

Background: There is a lack of consensus regarding the optimal method of assessing health-related quality of life (HR-QOL) among patients with metastatic renal cell carcinoma (mRCC). This study explored the perceived relevance of items that make up the Functional Assessment of Cancer Therapy Kidney Symptom Index-19 (FKSI-19), as judged by patients with mRCC.

Methods: This was a multinational cross-sectional survey.

View Article and Find Full Text PDF
Article Synopsis
  • Stereotactic body radiation therapy (SBRT) is proven to be a safe and effective option for delaying changes in systemic treatment for patients with metastatic renal cell carcinoma (mRCC), particularly in those with oligoprogressive disease.
  • In a study of 30 patients predominantly with clear cell renal cell carcinoma, genomic analyses showed that the duration of systemic treatment before and after radiation differed, with a median increase observed in treatment duration post-radiation.
  • The research indicated that patients showing a ratio of treatment duration pre and post-radiation of ≥1 had heightened expression in cell proliferation pathways, while those with a ratio of ≤1 presented enriched reactive oxygen species pathways, suggesting genomics could guide better radiation treatment decisions in m
View Article and Find Full Text PDF

This study evaluated the effects of palm kernel oil (PKO) in the diet of lambs on carcass characteristics, quality, and fatty acid profile of the meat. Forty uncastrated male Santa Inês lambs were used and divided among the treatments: PKOzero without inclusion; PKO1.3—added 1.

View Article and Find Full Text PDF

Since the approval of the COVID-19 vaccines, their safety and efficacy has been widely demonstrated in patients with cancer. However, there remain patients with reservations regarding vaccination. We aimed to assess genitourinary cancer patients' perceptions of the vaccines as well as barriers and influencers of decision-making through the completion of a questionnaire.

View Article and Find Full Text PDF

• With several newly approved regimens for RCC, cardiovascular risks must be considered during treatment selection. • Although uncommon, toxicities associated with these systemic therapies can have shortterm and long-term implications. • Although some toxicities may be lethal, others can be managed with early intervention.

View Article and Find Full Text PDF

The presence of microplastics in the aquatic ecosystem represents a major issue for the environment and human health. The capacity of organic pollutants to adsorb onto microplastic particles raises additional concerns, as it creates a new route for toxic compounds to enter the food web. Current knowledge on the impact of pristine and/or contaminated microplastics on aquatic organisms remains insufficient, and we provide here new insights by evaluating their biological effects in zebrafish (Danio rerio).

View Article and Find Full Text PDF

Over the last decade, the treatment paradigm of metastatic renal cell carcinoma has rapidly evolved, with notable changes in the front-line setting. Combination therapies involving the use of either doublet therapy with immune checkpoint inhibitors or combination VEGFR-directed therapies with immune checkpoint inhibitors have significantly improved clinical outcomes, including prolonged overall survival and durable response to treatment. We aim to highlight the Food and Drug Administration-approved front-line therapy options, the navigation of treatment selection, and the future directions of metastatic renal cell carcinoma therapies.

View Article and Find Full Text PDF